Compare ARK Genomic Revolution ETF (ARKG) vs iShares Global Tech ETF (IXN) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs iShares Global Tech ETF — how do they compare? ARK Genomic Revolution ETF trades at $40.83, while iShares Global Tech ETF trades at $138.25. Which is the better fit depends on your goals.
| ARKG | IXN | |
|---|---|---|
Sector | Sector/Thematic | Sector/Thematic |
52-Week High | $43.57 | $149.74 |
52-Week Low | $23.09 | $93.09 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
IXN trades at $140.73 with a slight 0.21% daily gain, showing bullish technical momentum with strong moving average support. The ETF maintains a neutral oscillator reading while offering global tech exposure. Recent dividend activity and mixed analyst sentiment reflect the current market positioning near key resistance levels.
The outlook remains cautiously optimistic given strong technical momentum, though valuation concerns and high expectations present near-term risks. Investment opportunity lies in continued tech sector leadership, while concentration risk and stretched valuations require careful monitoring for entry points.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About iShares Global Tech ETF
IXN provides exposure to global electronics, software, and hardware companies. It tracks the S&P Global 1200 Information Technology Index, covering tech leaders across both developed and emerging markets.
Read more on IXN →
